Shangwei Zhong

619 total citations
28 papers, 408 citations indexed

About

Shangwei Zhong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shangwei Zhong has authored 28 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Immunology. Recurrent topics in Shangwei Zhong's work include Epigenetics and DNA Methylation (6 papers), Electrochemical Analysis and Applications (4 papers) and Electrochemical sensors and biosensors (4 papers). Shangwei Zhong is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Electrochemical Analysis and Applications (4 papers) and Electrochemical sensors and biosensors (4 papers). Shangwei Zhong collaborates with scholars based in China, United States and South Korea. Shangwei Zhong's co-authors include Zihua Chen, Zhikang Chen, Jun‐Li Luo, Ji-Hak Jeong, Changhao Huang, Xiangjun Li, Hailin Wang, Yang Chen, Linfeng Mao and Hong Zou and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Shangwei Zhong

26 papers receiving 404 citations

Peers

Shangwei Zhong

ONCOL

IMMUN

Sandra Vorlová Germany

Lin Tan China

Christine Bruun Schiødt Denmark

Joanna Stanicka Ireland

Chang‐Tze Ricky Yu Taiwan

Xiaodan Qin China

Rebekka Kubisch Germany

Liangqiang Wu China

Ximing Tang China

Benjamin Neuditschko Austria

Sandra Vorlová Germany

Shangwei Zhong

404 ×1.7

84 ×0.9

ONCOL

100 ×1.6

65 ×1.2

IMMUN

38 ×0.7

Citations per year, relative to Shangwei Zhong Shangwei Zhong (= 1×) peers Sandra Vorlová

Countries citing papers authored by Shangwei Zhong

Since Specialization

Citations

This map shows the geographic impact of Shangwei Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangwei Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangwei Zhong more than expected).

Fields of papers citing papers by Shangwei Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangwei Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangwei Zhong. The network helps show where Shangwei Zhong may publish in the future.

Co-authorship network of co-authors of Shangwei Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Shangwei Zhong. A scholar is included among the top collaborators of Shangwei Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangwei Zhong. Shangwei Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wen, Jingyi, et al.. (2025). The role of GPI-anchored LY6/uPAR family proteins in connecting membrane microdomains with immune regulation and diseases. Critical Reviews in Oncology/Hematology. 216. 104971–104971.

Chang, Yujie, et al.. (2025). Combining gut microbiota modulation and immunotherapy: A promising approach for treating microsatellite stable colorectal cancer. Critical Reviews in Oncology/Hematology. 208. 104629–104629. 4 indexed citations

Liu, Yingzhe, et al.. (2024). MEIS2 suppresses breast cancer development by downregulating IL10. Cancer Reports. 7(5). e2064–e2064. 1 indexed citations

Liu, Qingqing, et al.. (2024). Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration. Cancers. 16(3). 597–597. 3 indexed citations

Chen, Xueyan, Weilin Wu, Ji-Hak Jeong, et al.. (2024). Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance. Science China Life Sciences. 67(7). 1413–1426. 3 indexed citations

Zhong, Shangwei, et al.. (2024). The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases. Biomarker Research. 12(1). 165–165. 8 indexed citations

Liu, Qingqing, Min Long, Xueyan Chen, et al.. (2023). DDX5 Functions as a Tumor Suppressor in Tongue Cancer. Cancers. 15(24). 5882–5882. 3 indexed citations

Wu, Danni, Yao Li, Cuiping Li, et al.. (2023). MDM2 Antagonist Nutlin-3 Stimulates Global DNA Hydroxymethylation by Enhancing p53–TET1 Signaling Axis. ACS Chemical Biology. 18(10). 2240–2248. 3 indexed citations

Jeong, Ji-Hak, Shangwei Zhong, Fuzhuo Li, et al.. (2022). Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of Experimental Medicine. 220(3). 17 indexed citations

10.

Zhong, Shangwei, Shoujiao Peng, Zihua Chen, Zhikang Chen, & Jun‐Li Luo. (2022). Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer. Pharmaceutics. 14(3). 498–498. 10 indexed citations

11.

Mao, Linfeng, Changhao Huang, Yi Xu, et al.. (2021). EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis. Oncogene. 40(20). 3610–3623. 51 indexed citations

12.

Zhong, Shangwei, Ji-Hak Jeong, Changhao Huang, et al.. (2021). Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 307–307. 17 indexed citations

13.

Huang, Changhao, Shangwei Zhong, HaJeung Park, Ji-Hak Jeong, & Jun‐Li Luo. (2020). A Simple and Efficient System for Producing Recombinant Human CXCL8 in Escherichia coli. Journal of Interferon & Cytokine Research. 40(9). 460–465. 2 indexed citations

14.

Zhong, Shangwei, Cuiping Li, Xiao Han, et al.. (2019). Idarubicin Stimulates Cell Cycle- and TET2-Dependent Oxidation of DNA 5-Methylcytosine in Cancer Cells. Chemical Research in Toxicology. 32(5). 861–868. 12 indexed citations

15.

Zhong, Shangwei, Ji-Hak Jeong, Zhikang Chen, Zihua Chen, & Jun‐Li Luo. (2019). Targeting Tumor Microenvironment by Small-Molecule Inhibitors. Translational Oncology. 13(1). 57–69. 90 indexed citations

16.

Huang, Changhao, Lai Chen, Shangwei Zhong, et al.. (2019). EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance. International Journal of Cancer. 146(7). 1937–1949. 55 indexed citations

17.

Zhong, Shangwei, Zhe Li, Ting Jiang, Xiangjun Li, & Hailin Wang. (2017). Immunofluorescence Imaging Strategy for Evaluation of the Accessibility of DNA 5-Hydroxymethylcytosine in Chromatins. Analytical Chemistry. 89(11). 5702–5706. 18 indexed citations

18.

Zhao, Bailin, Dapeng Zhang, Chengmin Li, et al.. (2017). ATPase activity tightly regulates RecA nucleofilaments to promote homologous recombination. Cell Discovery. 3(1). 16053–16053. 27 indexed citations

19.

Su, Jiali, Shangwei Zhong, Xiangjun Li, & Hong Zou. (2014). Determination of Trace Antimony by Square-Wave Adsorptive Cathodic Stripping Voltammetry at an Ex Situ Prepared Bismuth Film Electrode. Journal of The Electrochemical Society. 161(9). H512–H516. 17 indexed citations

20.

Zhang, Qing, Shangwei Zhong, Jiali Su, Xiangjun Li, & Hong Zou. (2013). Determination of Trace Chromium by Square-Wave Adsorptive Cathodic Stripping Voltammetry at an Improved Bismuth Film Electrode. Journal of The Electrochemical Society. 160(4). H237–H242. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact